EXPRESSION OF C-ERBB-2 PROTEIN, NEURON-SPECIFIC ENOLASE AND DNA FLOW-CYTOMETRY IN LOCALLY ADVANCED TRANSITIONAL CELL-CARCINOMA OF THE URINARY-BLADDER

被引:13
作者
BERNER, A
JACOBSEN, AB
FOSSA, SD
NESLAND, JM
机构
[1] NORWEGIAN RADIUM HOSP,DEPT MED ONCOL & RADIOTHERAPY,N-0310 OSLO,NORWAY
[2] INST CANC RES,OSLO,NORWAY
关键词
DNA PLOIDY; C-ERBB-2; NEURON-SPECIFIC ENOLASE; BLADDER NEOPLASM;
D O I
10.1111/j.1365-2559.1993.tb00131.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Expression of c-erbB-2 protein, neuron-specific enolase (NSE) and DNA ploidy was studied by immunohistochemistry and flow cytometry in formalin-fixed and paraffin-embedded specimens from 104 patients with locally advanced transitional cell carcinoma of the bladder. Positive membrane bound c-erbB-2 staining was found in 15% of the tumours, and 38% of the tumours were positive for NSE. Only one tumour stained positively for both NSE and c-erbB-2. Expression of c-erbB-2 protein and NSE was neither correlated to tumour stage nor to histopathological grade. The frequency of non-diploid tumours was 78% in 49 c-erbB-2/NSE negative tumours, 98% in 40 NSE positive tumours. and 100% in 16 c-erbB-2 positive tumours (P=0.004). Whether the c-erbB-2 expression is a useful prognostic marker in addition to other conventional parameters, remains to be shown.
引用
收藏
页码:327 / 333
页数:7
相关论文
共 31 条
[1]  
ASAMOTO M, 1990, ACTA PATHOL JAPON, V40, P322
[2]  
BORG A, 1991, ONCOGENE, V6, P137
[3]   AMPLIFICATION AND PROTEIN OVER-EXPRESSION OF THE NEU HER-2/C-ERBB-2 PROTOONCOGENE IN HUMAN BREAST CARCINOMAS - RELATIONSHIP TO LOSS OF GENE-SEQUENCES ON CHROMOSOME-17, FAMILY HISTORY AND PROGNOSIS [J].
BORRESEN, AL ;
OTTESTAD, L ;
GAUSTAD, A ;
ANDERSEN, TI ;
HEIKKILA, R ;
JAHNSEN, T ;
TVEIT, KM ;
NESLAND, JM .
BRITISH JOURNAL OF CANCER, 1990, 62 (04) :585-590
[4]   AMPLIFICATION AND OVER-EXPRESSION OF C-ERBB-2 IN TRANSITIONAL CELL-CARCINOMA OF THE URINARY-BLADDER [J].
COOMBS, LM ;
PIGOTT, DA ;
SWEENEY, E ;
PROCTOR, AJ ;
EYDMANN, ME ;
PARKINSON, C ;
KNOWLES, MA .
BRITISH JOURNAL OF CANCER, 1991, 63 (04) :601-608
[5]  
ERIKSTEIN B, 1988, HISTOL HISTOPATHOL, V3, P97
[6]   C-ERBB-2 ONCOGENE PRODUCT STAINING IN GASTRIC ADENOCARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY [J].
FALCK, VG ;
GULLICK, WJ .
JOURNAL OF PATHOLOGY, 1989, 159 (02) :107-111
[7]  
HARMES MH, 1978, TNM CLASSIFICATION M
[8]   METHOD FOR ANALYSIS OF CELLULAR DNA CONTENT OF PARAFFIN-EMBEDDED PATHOLOGICAL MATERIAL USING FLOW-CYTOMETRY [J].
HEDLEY, DW ;
FRIEDLANDER, ML ;
TAYLOR, IW ;
RUGG, CA ;
MUSGROVE, EA .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1983, 31 (11) :1333-1335
[9]   A COMPARATIVE-STUDY OF THE PEROXIDASE-ANTIPEROXIDASE METHOD AND AN AVIDIN-BIOTIN COMPLEX METHOD FOR STUDYING POLYPEPTIDE HORMONES WITH RADIOIMMUNOASSAY ANTIBODIES [J].
HSU, SM ;
RAINE, L ;
FANGER, H .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1981, 75 (05) :734-738
[10]   DEOXYRIBONUCLEIC-ACID FLOW-CYTOMETRY IN INVASIVE BLADDER-CARCINOMA - A POSSIBLE PREDICTOR FOR SUCCESSFUL BLADDER PRESERVATION FOLLOWING TRANSURETHRAL SURGERY AND CHEMOTHERAPY-RADIOTHERAPY [J].
HUG, EB ;
DONNELLY, SM ;
SHIPLEY, WU ;
HENEY, NM ;
KAUFMAN, DS ;
PREFFER, FI ;
SCHWARTZ, SM ;
COLVIN, RB ;
ALTHAUSEN, AF .
JOURNAL OF UROLOGY, 1992, 148 (01) :47-51